A Phase I Trial to Determine Safety and Efficacy of Chronic Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support

Trial Profile

A Phase I Trial to Determine Safety and Efficacy of Chronic Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Cenderitide (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jul 2017 Status changed from not yet recruiting to withdrawn prior to enrolment due to lack of funds.
    • 25 Jul 2017 Planned initiation date changed from 1 May 2017 to 30 Sep 2017.
    • 30 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top